Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression

Details for Australian Patent Application No. 2002233677 (hide)

Owner Eisai Co., Ltd.

Inventors Wakabayashi, Toshiaki; Ono, Naoto; Senba, Taro; Hata, Naoko; Funahashi, Yasuhiro

Agent Griffith Hack

Pub. Number AU-B-2002233677

PCT Pub. Number WO2002/066073

Priority 2001-44646 21.02.01 JP

Filing date 21 February 2002

Wipo publication date 4 September 2002

Acceptance publication date 6 January 2005

International Classifications

A61K 049/00 Preparations for testing

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/49 Investigating or analysing materials by specific methods not covered by groups - blood

A61K 031/404

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/4439

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 035/00 Antineoplastic agents

C07D 209/42 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/30 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002233677

6 January 2005 Application Accepted

  Published as AU-B-2002233677

5 May 2005 Standard Patent Sealed

29 September 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Method of examining effect of angiogenesis inhibitor mediated by the inhibition of integrin expression

10 May 2007 Assignment Registered

  Eisai Co., Ltd. The patent has been assigned to Eisai R&D Management Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002233678-EYE DROPS

2002233676-ANTIBODIES RECOGNIZING HELICOBACTER PYLORI AND METHOD OF DETECTING HELICOBACTER PYLORI